Иммунологическая коррекция препаратом Галавит больных колоректальным раком

Anan'ev Vs, В. М. Кулушев, Короткова Ольга Витальевна et al. · Российский биотерапевтический журнал · 2006

The article covers the results of surgical treating 83 patients with colorectal cancer admitted to the Proctology Department RCRS RAMS. The patients were shared between two groups: group 1 underwent a scheme-based immunotherapy by Galavit; group-2 was control group. A good tolerability of the drug was demonstrated and the immune-modeling effect produced by the drug on the immune-status parameters was detected in the patients of group 1 versus the controls. A reliable lower postoperative inflammatory complications in the patients, received Galavit were registered.

Cited by 0 works.

Authors